The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that first emerged in late 2019 is responsible for a pandemic of severe respiratory illness. People infected with this highly contagious virus can present with clinically inapparent, mild, or severe disease. Currently, the virus infect...

Descripción completa

Detalles Bibliográficos
Autores principales: Premkumar, Lakshmanane, Segovia-Chumbez, Bruno, Jadi, Ramesh, Martinez, David R., Raut, Rajendra, Markmann, Alena, Cornaby, Caleb, Bartelt, Luther, Weiss, Susan, Park, Yara, Edwards, Caitlin E., Weimer, Eric, Scherer, Erin M., Rouphael, Nadine, Edupuganti, Srilatha, Weiskopf, Daniela, Tse, Longping V., Hou, Yixuan J., Margolis, David, Sette, Alessandro, Collins, Matthew H., Schmitz, John, Baric, Ralph S., de Silva, Aravinda M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292505/
https://www.ncbi.nlm.nih.gov/pubmed/32527802
http://dx.doi.org/10.1126/sciimmunol.abc8413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292505/
https://www.ncbi.nlm.nih.gov/pubmed/32527802
http://dx.doi.org/10.1126/sciimmunol.abc8413

Ejemplares similares